LEVETIRACETAM VIATRIS 500 mg, film-coated tablet 60 tablets, CIP 3400930151167
Active ingredients: (S)-etiracetam
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet60 tablets, CIP 3400930151167orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVETIRACETAM VIATRIS 500 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 60 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Jul 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65523468CIP73015116CIP133400930151167Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVÉTIRACÉTAMcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.